Literature DB >> 27804146

Monotonic single-index models to assess drug interactions.

Yubing Wan1, Susmita Datta2, J Jack Lee3, Maiying Kong4.   

Abstract

Although single-index models have been extensively studied, the monotonicity of the link function f in the single-index model is rarely studied. In many situations, it is desirable that f is monotonic, which results in a monotonic single-index model that can be very useful in economics and biometrics. In this article, we propose a monotonic single-index model in which the link function is constructed using penalized I-splines along with constraints on coefficients to achieve monotonicity of the link function f. An algorithm to estimate the single-index parameters and the link function is developed, and the sandwich estimate of the variance of the index parameters is provided. We propose to apply this monotonic single-index model to estimate the dose-response surface and assess drug interactions while considering the variability of the observed data. An extensive simulation study was carried out to evaluate the performance of the proposed monotonic single-index model. A case study is provided to illustrate the application of the proposed model to estimate the dose-response surface and assess drug interactions. Both the simulation and case study show that the proposed monotonic single-index model works very well.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  I-spline; dose-response surface; drug interaction; single-index model

Mesh:

Year:  2016        PMID: 27804146      PMCID: PMC5217167          DOI: 10.1002/sim.7158

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Experimental design and sample size determination for testing synergism in drug combination studies based on uniform measures.

Authors:  Ming Tan; Hong-Bin Fang; Guo-Liang Tian; Peter J Houghton
Journal:  Stat Med       Date:  2003-07-15       Impact factor: 2.373

2.  A flexible unified approach to the analysis of pre-clinical combination studies.

Authors:  Chris Harbron
Journal:  Stat Med       Date:  2010-07-20       Impact factor: 2.373

3.  A generalized response surface model with varying relative potency for assessing drug interaction.

Authors:  Maiying Kong; J Jack Lee
Journal:  Biometrics       Date:  2006-12       Impact factor: 2.571

4.  A semiparametric response surface model for assessing drug interaction.

Authors:  Maiying Kong; J Jack Lee
Journal:  Biometrics       Date:  2007-09-26       Impact factor: 2.571

5.  Interaction index and different methods for determining drug interaction in combination therapy.

Authors:  J J Lee; M Kong; G D Ayers; R Lotan
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

6.  Statistical modeling of the effects of drug combinations.

Authors:  J L Plummer; T G Short
Journal:  J Pharmacol Methods       Date:  1990-07

Review 7.  What is synergy?

Authors:  M C Berenbaum
Journal:  Pharmacol Rev       Date:  1989-06       Impact factor: 25.468

8.  Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors:  J G Wagner
Journal:  J Theor Biol       Date:  1968-08       Impact factor: 2.691

Review 9.  The search for synergy: a critical review from a response surface perspective.

Authors:  W R Greco; G Bravo; J C Parsons
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

10.  Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil.

Authors:  S Savelev; E Okello; N S L Perry; R M Wilkins; E K Perry
Journal:  Pharmacol Biochem Behav       Date:  2003-06       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.